Metoprolol recalls

The FDA has published 30 recalls involving Metoprolol since 2012. The latest was reported on 11 Mar 2026. Most were for potency & assay. Wockhardt Usa has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls30since 2012

Last 12 months4reported

Class I00% of total

Ongoing8latest 11 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 1Jul 2 0 0Oct 0 0 0Jan '26 0 4 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 28 93%Class III 2 7%

Why metoprolol is recalled

Companies

Wockhardt Usa620%
Teva Pharmaceuticals USA517%
Aidapak Services310%
Dr. Reddy's Laboratories310%
Rubicon Research Private27%
Westminster Pharmaceuticals27%
Mckesson Medical-Surgical Inc. Corporate Office13%
Cardinal Healthcare13%

Brands

By year

2026413%
2025310%
202427%
202227%
202113%
2018413%
2015413%
2014827%
201313%
201213%

Ongoing metoprolol recalls

8 active

Reported	Class	Recall	Company	Reason	Where
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
20 Aug 2025Drug	CLASS II	Metoprolol Tartrate Tablets, USP, 50 mg recalled	Westminster Pharmaceuticals	Nitrosamine Impurity	Nationwide
20 Aug 2025Drug	CLASS II	Metoprolol Tartrate Tablets, USP, 100 mg recalled	Westminster Pharmaceuticals	Nitrosamine Impurity	Nationwide

All metoprolol recalls, newest first

30 total

Reported	Class	Recall	Company	Reason	Where
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
20 Aug 2025Drug	CLASS II	Metoprolol Tartrate Tablets, USP, 50 mg recalled	Westminster Pharmaceuticals	Nitrosamine Impurity	Nationwide
20 Aug 2025Drug	CLASS II	Metoprolol Tartrate Tablets, USP, 100 mg recalled	Westminster Pharmaceuticals	Nitrosamine Impurity	Nationwide
9 Jul 2025Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 25 mg recalledMetoprolol Succinate	Granules Pharmaceuticals	Potency & Assay	Nationwide
5 Jun 2024Drug	CLASS II	Metoprolol Tartrate Tablets USP, 25mg recalledMetoprolol Tartrate	Rubicon Research Private	Foreign Material	Nationwide
3 Jan 2024Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 50 mg recalledMetoprolol Succinate	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide
15 Jun 2022Drug	CLASS II	Metoprolol tablets 50 mg botte recalled by Mckesson Medical-Surgical	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Metoprolol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.